UNDERWRITING AGREEMENT between PLASMATECH BIOPHARMACEUTICALS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters PLASMATECH BIOPHARMACEUTICALS, INC.Underwriting Agreement • October 24th, 2014 • Plasmatech Biopharmaceuticals Inc • Pharmaceutical preparations • New York
The undersigned, PlasmaTech Biopharmaceuticals, Inc. a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of PlasmaTech Biopharmaceuticals, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
FORM OF WARRANT AGENCY AGREEMENTForm of Warrant Agency Agreement • October 24th, 2014 • Plasmatech Biopharmaceuticals Inc • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT made as of October , 2014 (the “Issuance Date”), between PlasmaTech Biopharmaceuticals, Inc., a Delaware corporation, with offices at 4848 Lemmon Ave., Suite 517, Dallas, Texas 75219 (the “Company”), and American Stock Transfer & Trust Company, LLC, with offices at 6201 15th Avenue, Brooklyn, New York 11219 (the “Warrant Agent”).
